Corporate sector updates: Kraft Heinz investment and BioMarin stock shifts

Various companies have reported significant financial shifts and strategic updates. Kraft Heinz is investing an additional $100 million into its transformation program, focusing on marketing and innovation to drive growth. This brings its total marketing expenditure toward a goal of 6% of net sales by 2026.

In the biotechnology sector, Pacer Advisors Inc. significantly reduced its holdings in BioMarin Pharmaceutical Inc., selling 913,713 shares during the first quarter. Meanwhile, other institutional investors such as Norges Bank and Viking Global Investors LP have recently adjusted their positions in the company.

Amerant Bancorp Inc. has received a